Ken Griffin's position in Haemonetics is currently worth $1.9 Million. That's 0.00% of their equity portfolio (2305th largest holding). The first Haemonetics trade was made in Q2 2013. Since then Ken Griffin bought shares 39 more times and sold shares on 44 occasions. The investor's estimated purchase price is $1.9 Million, resulting in a loss of 0.0%.